Top

Published in:

01-04-2017 | Original Scientific Report

Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma

Authors: Hiroya Iida, Masaki Kaibori, Shogo Tanaka, Shigekazu Takemura, Hiroshi Wada, Fumitoshi Hirokawa, Takuya Nakai, Michihiro Hayashi, Hidetoshi Eguchi, Shoji Kubo

Published in: World Journal of Surgery | Issue 4/2017

Abstract

Background and objectives

We determined the rates of initial lymph node metastasis following curative resection of mass-forming type-intrahepatic cholangiocarcinoma (ICC) in patients with and without hepatitis virus infection.

Methods

We enrolled 87 patients between January 2000 and December 2013 with ICC without preoperative lymph node metastasis and without lymph node dissection. Patients included 32 who were seropositive for hepatitis B or C virus (virus group) and 55 who had no evidence of hepatitis virus infection (nonvirus group). Postsurgical outcomes and initial recurrence of the groups were compared, and we identified the risk factors for lymph node metastasis as initial recurrence.

Results

Platelet counts and prothrombin activities were significantly lower in the virus group compared with those of the nonvirus group. The number of patients with chronic hepatitis or liver cirrhosis was significantly higher in the virus group compared with the nonvirus group as well as their respective rates of recurrence-free survival. One patient (3%) in the virus group and 14 patients (25%) in the nonvirus group had lymph node metastasis as initial recurrence (p = 0.007). Multivariate analysis revealed that the absence of hepatitis virus infection as an independent risk factor (p = 0.047).

Conclusion

Hepatitis virus-associated mass-forming-type ICC confers a low risk of lymph node metastasis as initial postoperative recurrence.

Kudo M, Izumi N, Ichida T et al (2016) Report of the 19th follow-up survey of primary liver cancer in japan. Hepatol Res 46:372–390CrossRefPubMed

Lubezky N, Facciuto M, Harimoto N et al (2015) Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci 22:124–130CrossRefPubMed

Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357CrossRefPubMed

Khan SA, Taylor-Robinson SD, Toledano MB et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813CrossRefPubMed

Utada M, Ohno Y, Tamaki T et al (2014) Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan. J Epidemiol 24(193–19):9

Ikeda A, Miyashiro I, Nakayama T et al (2013) Descriptive epidemiology of bile duct carcinoma in Osaka. Jpn J Clin Oncol 43(1150–115):5

Parkin DM, Ohshima H, Srivatanakul P et al (1993) Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomark Prev 2:537–544

Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125CrossRefPubMed

Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10:77–82CrossRef

10.

Kubo S, Kinoshita H, Hirohashi K et al (1995) Hepatolithiasis associated with cholangiocarcinoma. World J Surg 19:637–641. doi:10.1007/BF00294744 CrossRefPubMed

11.

Watanapa P, Watanapa WB (2002) Liver fluke-associated cholangiocarcinoma. Br J Surg 89:962–970CrossRefPubMed

12.

Kobayashi M, Ikeda K, Saitoh S et al (2000) Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 88:2471–2477CrossRefPubMed

13.

Yamamoto S, Kubo S, Hai S et al (2004) Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95:592–595CrossRefPubMed

14.

Tyson GL, El-Serag HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54:173–184CrossRefPubMedPubMedCentral

15.

Kubo S, Nakanuma Y, Takemura S et al (2014) Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J Hepatobiliary Pancreat Sci 21:479–488CrossRefPubMed

16.

Kubo S, Kinoshita M, Takemura S et al (2014) Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:809–817CrossRefPubMed

17.

Kinoshita M, Kubo S, Nakanuma Y et al (2016) Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma. J Hepatobiliary Pancreat Sci 23:92–101CrossRefPubMed

18.

Welzel TM, Graubard BI, El-Serag HB et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol 5:1221–1228CrossRefPubMedPubMedCentral

19.

Shaib YH, El-Serag HB, Davila JA et al (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128:620–626CrossRefPubMed

20.

Hai S, Kubo S, Yamamoto S et al (2005) Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 22:432–439CrossRefPubMed

21.

Wakabayashi H, Hashimoto N, Okano K et al (2008) Clinicopathological comparison between intrahepatic cholangiocarcinoma arising in livers positive and negative for hepatitis B or C virus. Liver Int 28:717–718CrossRefPubMed

22.

Ariizumi S, Kotera Y, Takahashi Y et al (2011) Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 104:130–139CrossRefPubMed

23.

Zhou HB, Wang H, Li YQ et al (2011) Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 17:1292–1303CrossRefPubMedPubMedCentral

24.

Zhang L, Cai JQ, Zhao JJ et al (2010) Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 101:233–238CrossRefPubMed

25.

Uenishi T, Nagano H, Marubashi S et al (2014) The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol 110:176–181CrossRefPubMed

26.

Kubo S, Uenishi T, Yamamoto S et al (2004) Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 29:223–227CrossRefPubMed

27.

Li YY, Li H, Lv P et al (2011) Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 15:608–613CrossRefPubMed

28.

Komuta M, Govaere O, Vandecaveye V et al (2012) Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 55:1876–1888CrossRefPubMed

29.

Fujimoto A, Furuta M, Shiraishi Y et al (2015) Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat Commun 6:6120CrossRefPubMed

30.

Aishima S, Oda Y (2015) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci 22:94–100CrossRefPubMed

31.

Uenishi T, Hirohashi K, Kubo S et al (2001) Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 88:969–974CrossRefPubMed

32.

Uenishi T, Ariizumi S, Aoki T et al (2014) Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 21:499–508CrossRefPubMed

33.

Uchiyama K, Yamamoto M, Yamaue H et al (2011) Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18:443–452CrossRefPubMed

34.

Uenishi T, Yamamoto T, Takemura S et al (2014) Surgical treatment for intrahepatic cholangiocarcinoma. Clin J Gastroenterol 7:87–93CrossRefPubMed

35.

Yamamoto M, Ariizumi S (2011) Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today 41:896–902CrossRefPubMed

36.

Sakamoto Y, Kokudo N, Matsuyama Y et al (2016) Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer 122:61–70CrossRefPubMed

37.

Ribero D, Pinna AD, Guglielmi A et al (2012) Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 147:1107–1113CrossRefPubMed

38.

Marubashi S, Gotoh K, Takahashi H et al (2014) Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively-determined anatomic invasion level and number of tumors. Dig Dis Sci 59:201–213CrossRefPubMed

39.

Luo X, Yuan L, Wang Y et al (2014) Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study. J Gastrointest Surg 18:562–572CrossRefPubMed

40.

Ellis MC, Cassera MA, Vetto JT et al (2011) Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors. HPB (Oxford) 13:59–63CrossRef

41.

Guglielmi A, Ruzzenente A, Campagnaro T et al (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33:1247–1254. doi:10.1007/s00268-009-9970-0 CrossRefPubMed

42.

Bektas H, Yeyrek C, Kleine M et al (2015) Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience. J Hepatobiliary Pancreat Sci 22:131–137CrossRefPubMed

43.

Murakami Y, Uemura K, Sudo T et al (2012) Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. J Hepatobiliary Pancreat Sci 19:306–313CrossRefPubMed

44.

Shimada K, Sano T, Nara S et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145:411–416CrossRefPubMed

45.

Shimada M, Yamashita Y, Aishima S et al (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463–1466CrossRefPubMed

46.

Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system World Health Organization of Tumours, 4th edn. World Health Organization, Lyon, pp 217–224

47.

Aishima S, Kuroda Y, Nishihara Y et al (2007) Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 31:1059–1067CrossRefPubMed

48.

Pang YY (2002) The brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2: 333-39. HPB (Oxford) 4:99 (author reply 99–100) CrossRef

49.

Lee CH, Chang CJ, Lin YJ et al (2009) Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 100:1765–1770CrossRefPubMedPubMedCentral

50.

Zhou Y, Zhao Y, Li B et al (2012) Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 12:289CrossRefPubMedPubMedCentral

51.

Zhou YM, Cao L, Li B et al (2012) Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 11:532–535CrossRefPubMed

52.

Luh F, Kuei A, Fann P et al (2009) Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review. Anticancer Res 29:3239–3243PubMed

53.

Liu W, Chen JR, Hsu CH et al (2012) A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology 56:2268–2276CrossRefPubMed

54.

Ariizumi S, Yamamoto M (2015) Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surg Today 45:682–687CrossRefPubMed

55.

Adachi T, Eguchi S (2014) Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. J Hepatobiliary Pancreat Sci 21:162–168CrossRefPubMed

Title: Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma
Authors: Hiroya Iida
Masaki Kaibori
Shogo Tanaka
Shigekazu Takemura
Hiroshi Wada
Fumitoshi Hirokawa
Takuya Nakai
Michihiro Hayashi
Hidetoshi Eguchi
Shoji Kubo
Publication date: 01-04-2017
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 4/2017
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-016-3843-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma

Abstract

Background and objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2017

Completely Thoracoscopic Diaphragmatic Plication

Postoperative Complications of Laparoscopic Cholecystectomy for Acute Cholecystitis: A Comparison to the ACS-NSQIP Risk Calculator and the Tokyo Guidelines

The Use of Autologous Peritoneum for Complete Caval Replacement Following Resection of Major Intra-abdominal Malignancies

Adrenal Injuries: Historical Facts and Modern Truths

Comparative Validation of Abdominal CT Models that Predict Need for Surgery in Adhesion-Related Small-Bowel Obstruction

Prognostic Impact of Further Treatments on Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma: Verification Using Inverse Probability of Treatment Weighting